Scientific Program

June 28th, 2018

Friends of Georgia

Location: Main Hall

08.00 – 10.15 Bladder Cancer – Part I
08.00 – 08.15 Incidence and mortality of bladder cancer in the world.
08.15 – 08.45 Genomic classification of bladder cancer
– NMIBC 
– MIBC
08.45 – 09.00 Optical enhancement of NMIBC: An update
09.00 – 09.15 BCG failures: Definitions, management, outcomes
09:15 – 09.30 Follow-up in non-muscle invasive bladder cancer: What is the ideal?
09.30 – 09.45 Gender specific differences in bladder cancer
 
09.45 – 10.15 Panel: Challenging cases in bladder cancer
 
10.15 – 10.30 Coffee Break
 
10.30 – 12.15 Bladder cancer – Part II
10.30 – 11.00 Minimally invasive radical cystectomy: It is worth to do?
– Yes
– No
11.00 – 11.15 The potential role of sex steroids and their specific receptors in bladder cancer
11.15 – 11.30 Frailty and bladder cancer
11.30 – 12.00 Systemic treatment in metastatic disease
– Chemotherapy
– Immunotherapy
11.30 – 11.45 The role of surgery in metastatic bladder cancer
 
11.45 – 12.15 Panel: Challenging cases in bladder cancer
 
12.15 – 13.15 Lunch

 

B2B Renal Cancer

Location: Main Hall

13.15 – 14.50 Mechanism and Biology- Prevention and Diagnosis
13.15 – 13.20 Introduction
13.20 – 13.35 Integrative design for cancer prevention and therapy
13.35 – 13.50 Rationale for renal biopsy
13.50 – 14.05 Implications of next generation sequencing for renal cancer – Liquid biopsy
14.05 – 14.20 Novel diagnostics and surgical interventions – Clinical Integration and Translation
14.20 – 14.35 Frequent incidental diagnosis of small indolent cancers -active surveillance-
14.35 – 14.50 Cystic tumors- challenges
 
14.50 – 15.15 Coffee Break
 
15.15 – 17.15 Biology and Engineering- Diagnosis and Treatment
15.15 – 15.30 Image guided minimally invasive procedures – Focal
15.30 – 15.45 Stereotactic ablative radiotherapy for primary renal cancer
15.45 – 16.00 Discussion
16.00 – 16.15 Locally advanced-high risk renal cell carcinoma in the neoadjuvant/adjuvant therapy ARENA
16.15 – 16.30 Experimental and near term future -molecular imaging-
16.30 – 16.45 Immunogenomics -RCC Integrating immunotherapy with the existing drugs-
16.45 – 17.00 Protein-level biomarkers in determining the prognosis and in developing treatment strategies
17.00 – 17.15 Which direction in diagnosis and treatment are we heading? My vision

 

Workshop

17.00 – 18.00 Course-1

Location: Room 2

 

June 29th, 2018
08.00 – 09.00 Opening Remarks
 

Perspectives

Location: Main Hall

09.00 – 10.00 Localised Disease
09.00 – 09.15 When biopsy with mp-MRI?
09.15 – 09.30 mp-MRI in Active Surveillance
09.30 – 09.45 Stereotactic radiotherapy for localized prostate cancer
09.45 – 10.00 Focal therapy: From patient selection to outcomes
 
10.00 – 11.00 Locally Advanced-Oligometastatic
10.00 – 10.15 Imaging in locally advanced and oligometastatic prostate cancer
10.15 – 10.30 Urologist Perspective
10.30 – 10.45 Radiation oncologist perspective
10.45 – 11.00 Regional LNs in prostate cancer: All aspects
 
11.00 – 11.30 Coffee Break
 
11.30 – 12.30 Metastatic Disease – Castration-Resistant Prostate Cancer
11.30 – 11.45 PSMA based imaging and radioligand treatment
11.45 – 12.00 What Combination Drugs with Radium-223 Are Best for Treating Prostate Cancer?
12.00 – 12.15 Conundrums in CHAARTED, LATITUDE and STAMPEDE clinical trials
12.15 – 12.30 Changing role of agents targeting adrenal androgen synthesis.
 
12.30 – 14.00 Lunch
 
14.00 – 15.00 Panel: Role of local radiation therapy/surgery in metastatic setting
 
15.00 – 16.00 Panel: Rising PSA treated with Radiotherapy/ Radical Prostatectomy
 
16.00 – 16.30 Coffee Break
   
16.30 – 17.45 Regional Societies Session
16.30 – 16.45 Immigrants: How to provide care for each patient?
16.45 – 17.00 WHO perspective
17.00 – 17.15 Racial/Ethnic/Socioeconomic Disparities (AD/Targeted/Chemo)
17.15 – 17.30 Cancer stage distribution in the immigrant and host populations
17.30 – 17.45 Genetic variants in different populations
17.30 – 17.45 EBU beyond Europe
 

Young Urooncologists

Residents Meet Masters

Location: Room 2

16.00-16.50 Opportunities
16:00-16:10 Residency training and development in TAU
16:10-16.20 Residency training and development in USA
16:20-16:30 Residency training and development in EAU
16:30-16:40 Residency training and development in SIU
16:40-16:50 What is EUA planning for the residents?
 
17.00-18.00 Education
17:00-17:15 Fundamentals of laparoscopy and education of residents
17:15-17:30 Fundamentals of Robotic Urology and Resident education
17:30-17:45 How to Write a paper?
17:45-18:00 The path, residency to mastership
 

Stay Connected

Location: Room 6

16.00-18.00 Stay Connected
  Prostate Cancer
  Bladder Cancer
  Testis Tumors
  UTT
  Renal Cancer
 

Workshop

16.00 – 18.00 Course-2

Location: Room 3

16.00 – 18.00 Course-3

Location: Room 4

16.00 – 18.00 Course-4

Location: Room 5

 

June 30th, 2018

Perspectives

Location: Main Hall

08.00 – 09.30 Localised Renal Cancer
08.00 – 08.15 Modern Imaging of Renal Tumors 
08.15 – 08.30 The Role of Lymph Node Dissection in the Management of Renal Cell Carcinoma
08.30 – 09.30 Adjuvant Therapy for RCC – Current situation and upcoming trials 
 
09.30 – 10.15 Oligometastastic – Metastatic Disease
09.30 – 09.45 What should be the next step?
09.45 – 10.00 Late-Relapse mRCC
10.00 – 10.15 Absence of complete response
 
10.15 – 10.30 Coffee Break
 
10.30 – 11.30 Panel: Muscle invasive bladder cancer
Radical cytectomy
Chemotherapy
Bladder preservation strategies
 
11:30 – 12:05 Session
11.30 – 11.45 UTT: New Standards
11.45 – 12.05 The Endourological Society President’s Lecture
 
12.05 – 13.00 Lunch
 
13.00 – 14.00 Pediatric Urooncology Update:  Case-Based Panel Discussion
14.00 – 15.00 Disasters of Masters
 

AS – LIVE

Location: Main Hall

15.00 – 15.20 Image guided surgery prostate/kidney
15.20 – 15.40 Perineal Prostatectomy
15.40 – 16.00 Robotic Assisted Perineal Prostatectomy
16.00 – 16.20 UTT endoscopic management
16.20 – 16.40 UTT endoscopic management
16.40 – 16.50  RALP in large prostates
16.50 – 17.00  Blader Cancer –enucleation-
17.00 – 17.40 Partial Nephrectomy Clampless
– Yes
– No
   

Urooncology

Location: Room 1

15:00 – 15:45 Advanced Bladder Cancer
15.00 – 15.15 Immunotherapy in Bladder Cancer: Update
15.15 – 15.30 Chemotherapy moving forward in combination with immunotherapy
15.30 – 15.45 Bladder Cancer BioMarkers: Optimal Utilization for Diagnosis and Recurrence
 

Workshop

16.00 – 18.00 Course-5

Location: Room 2

16.00 – 18.00 Course-6

Location: Room 3

 

July 1st, 2018
08.00 – 09.00 Take home messages

Location: Main Hall